Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
GPT HealthcareNSE:GPTHEALTH +0.85%44 EV-to-EBIT is 18.67 as of Sep. 01, 2026, which is 0% below its 10-year median of 18.68. GuruFocus rates NSE:GPTHEALTH with a GF Score™ of 44/100. The stock has 1 warning sign investors should review. Among 477 Healthcare Providers & Services companies, GPT Healthcare ranks worse than 61.84% on this metric.
The historical rank and industry rank for GPT Healthcare's EV-to-EBIT or its related term are showing as below:
NSE:GPTHEALTH'
s EV-to-EBIT Range Over the Past 10 Years
Min: 14.38 Med: 18.68 Max: 28.53
Current: 18.66
During the past 6 years, the highest EV-to-EBIT of GPT Healthcare was 28.53. The lowest was 14.38. And the median was 18.68.
NSE:GPTHEALTH's EV-to-EBIT is ranked worse than 61.84% of 477
companies
in the Healthcare Providers & Services industry
Industry Median: 15.67
vs NSE:GPTHEALTH: 18.66
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
GPT Healthcare's Enterprise Value for the quarter that ended in Jun. 2026 was ₹12,186 Mil.
GPT Healthcare's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹696 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GPT Healthcare EV-to-EBIT Related Terms
GPT Healthcare EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for GPT Healthcare's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:GPTHEALTH vs HCA, THC, EHC: EV-to-EBIT Comparison
For the Medical Care Facilities subindustry, GPT Healthcare's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GPT Healthcare EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, GPT Healthcare's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where GPT Healthcare's EV-to-EBIT falls into.
GPT Healthcare's current Enterprise Value is ₹12,996 Mil.
GPT Healthcare's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹696 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GPT Healthcare (NSE:GPTHEALTH) has a EV-to-EBIT of 18.67 as of Sep. 01, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on GPT Healthcare and its competitors. This is near median its historical median of 18.68. Over the past decade, GPT Healthcare's EV-to-EBIT has ranged from 14.38 to 28.53. According to the industry distribution chart, GPT Healthcare ranks #295 out of 477 companies in the Healthcare Providers & Services industry, placing it in the top 61.8%.
Is GPT Healthcare's EV-to-EBIT too high?
GPT Healthcare's current EV-to-EBIT of 18.67 is near median its 10-year median of 18.68. Over the past 10 years, this metric has ranged from a low of 14.38 to a high of 28.53. The Healthcare Providers & Services industry median EV-to-EBIT is 15.67. GPT Healthcare's value of 18.67 is 19.1% above this industry median. Based on the distribution chart, GPT Healthcare ranks #295 out of 477 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, GPT Healthcare has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does GPT Healthcare's EV-to-EBIT compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, GPT Healthcare ranks #295 out of 477 companies for EV-to-EBIT. This places GPT Healthcare in the lower half of its industry. The industry median EV-to-EBIT is 15.67. GPT Healthcare's value of 18.67 is 19.1% above this benchmark. Historically, GPT Healthcare's own EV-to-EBIT has ranged from 14.38 to 28.53 over the past decade. While the company's 10-year median is 18.68 vs. the industry median of 15.67, GPT Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.67, based on 477 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. GPT Healthcare's current EV-to-EBIT of 18.67 is 19.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on GPT Healthcare and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GPT Healthcare's current EV-to-EBIT is 18.67, which is near median its own 10-year median of 18.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GPT Healthcare stock overvalued right now?
GPT Healthcare (NSE:GPTHEALTH) has a current EV-to-EBIT of 18.67. The current EV-to-EBIT is 18.67, which is near median its 10-year median of 18.68 and 19.1% above the Healthcare Providers & Services industry median of 15.67. GPT Healthcare's overall GF Score™ is 44/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For GPT Healthcare (NSE:GPTHEALTH), the current EV-to-EBIT is 18.67 as of Sep. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
GPT Healthcare Ltd is engaged in the healthcare sector. It operates a chain of mid-sized full-service hospitals under the ILS brand. It provides integrated healthcare services, with a focus on secondary and tertiary care and operates four multispecialty hospitals in Dum Dum, Salt Lake and Howrah in West Bengal and Agartala in Tripura with a total capacity of approximately 561 beds. It offers a comprehensive range of healthcare services across over 35 specialities and super specialities, including internal medicine and diabetology, nephrology (including renal transplants), laparoscopic and general surgery, gynaecology and obstetrics, critical care, gastroenterology, orthopaedics and joint replacements, interventional cardiology, neurology, neurosurgery, paediatrics, and neonatology.
44GF Score
Get the complete analysis for NSE:GPTHEALTH
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:GPTHEALTH has been successfully added to your 
